Effects of Nebivolol on Left Ventricular and Left Atrial Morphodynamics in Adults With Hypertension and Isolated Diastolic Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2017
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 22 Jun 2016 Status changed from recruiting to completed.
- 23 Sep 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 according to the ClinicalTrials.gov record.
- 23 Sep 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 according to the ClinicalTrials.gov record.